Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.

A rat model of acute pulmonary air embolism (APAE) was developed. These animals had a higher right ventricular systolic pressure (RVSP) (+ 69% at 15-minute peak, and 21-34% at 30-180 minutes), as well as a reduced mean arterial blood pressure (10-20% at 60-180 minutes), heart rate (20-26% at 60-180 minutes) and PaO2 (9-11% at 30-180 minutes) compared with control rats. The role of the endothelin (ET) system, known to be involved in pulmonary hypertension of various etiologies, was investigated by evaluating the effect of the four classes of ET blockers: ET-converting enzyme inhibitor (ECEi) (CGS 35066), selective endothelin-A receptor antagonist (ETA-Ra) (Atrasentan, ABT-627), endothelin-B receptor antagonist (ETB-Ra) (A-192621) or mixed endothelin-A/endothelin-B receptor antagonist (ETA/B-Ra) (A-182086) in this animal model. All four were effective, to various degrees, at reducing the APAE-induced rise in RVSP. The relative efficacy of those compounds in reducing the acute elevation (15 minutes) of RVSP was ECEi >or= ETA/B-Ra >> ETA-Ra = ETB-Ra. The sustained elevation (30-180 minutes) of RVSP was totally abolished by ECEi and attenuated by other ET blockers with a relative efficacy of ETA-Ra > ETA/B-Ra >or= ETB-Ra. ET receptor antagonists did not affect right ventricular basal tone (control rats) whereas ECEi reduced it by up to 12% after 2 hours. The APAE reduction in mean arterial blood pressure was unaffected by ETARa, was completely normalized by ETB-Ra, but was further reduced by either ETA/B-Ra or ECEi. The basal mean arterial blood pressure in control rats was unaffected by ETA-Ra, was elevated by ETB-Ra, but was depressed by ETA/B-Ra and ECEi. All ET blockers maintained normal oxygen saturation in APAE. These results support a role for ETs in rat APAE, since ET blockers can attenuate the cardiopulmonary deterioration and blood gas exchange. However, modulation of the central hemodynamic profile is more complex and may limit the usefulness of some ET blockers.

A novel procedure for daily measurements of hemodynamical, hematological, and biochemical parameters in conscious unrestrained rats.

Accurate and chronic measurements of various parameters in conscious animals are fundamental for depicting pathological chronic conditions and their etiology in many experimental models, but they are often difficult to achieve. The aim of the present work was to develop and describe step-by-step a reproducible surgical procedure and daily manipulations for continuous, chronic use of conscious rats as models towards a better understanding of various cardiovascular and renal diseases and the testing of novel pharmacological drugs. The complete apparatus involved the use of a series of specialized devices (harness, rotating swivel, revolving arm) supporting a flexible, permanently implanted vascular catheter into the left femoral artery up to the abdominal aorta connected to a miniaturized individual peristaltic pump for delivering fluid at a constant rate. Such a set-up also enabled easy, quick, and reproducible daily blood sampling for the evaluation of more than 20 parameters, including the monitoring of heart rate (HR) and blood pressure in freely moving conscious rats. The overall success and survival rate reached 98% over 14 days and could be extended further. This model represents a much needed and valuable advance in surgical research techniques to evaluate the hemodynamic, hematological, biochemical, pharmacokinetic, and toxicological profile of any new drugs over time in conscious animal models such as rats. What makes this procedure satisfactory is the long-term reliable arterial access and reproducibility of the methodological approach for accurate and continuous measurements, minimizing the stress or invasiveness associated with the use of currently employed systems.